CGeneTech Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 83

Employees

  • Latest Deal Type
  • IPO

  • Investors
  • 18

CGeneTech General Information

Description

Owner and operator of a bio-pharmaceutical company intended to manufacture and sell synthetic DNA purification kits used for research and medicinal purposes. The company's services together with offshore sites, providing clients with a comprehensive portfolio of efficient and cost-effective chemistry systems for all stages of small molecule drug discovery, from initial hit generation, to hit-to-lead, to lead optimization, pre-clinical candidate identification, process research and scale-up, enabling pharmaceutical and biotech clients to increase their productivity by getting catalog products and custom synthesis services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building C11, Biomedical Industrial Park
  • No. 218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1st Floor, Building C11, Biomedical Industrial Park
  • No. 218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512

CGeneTech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CGeneTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. IPO 25-Sep-2025 Completed Generating Revenue
11. Secondary Transaction - Private 12-Mar-2025 Completed Generating Revenue
10. Later Stage VC (Series C) 26-Aug-2024 Completed Generating Revenue
9. Later Stage VC (Series B1) 17-Mar-2023 Completed Generating Revenue
8. Later Stage VC (Series B) 05-Mar-2021 Completed Generating Revenue
7. Secondary Transaction - Private 07-Jan-2020 Completed Generating Revenue
6. Later Stage VC (Series A1) 08-Oct-2019 Completed Generating Revenue
5. Later Stage VC 28-Dec-2018 Completed Generating Revenue
4. Later Stage VC (Series A) 15-Dec-2017 $10.6M $13.5M Completed Generating Revenue
3. Later Stage VC 13-Sep-2017 $1.52M $2.93M Completed Generating Revenue
To view CGeneTech’s complete valuation and funding history, request access »

CGeneTech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,235,636 $1.13 $1.13 1x $1.13 4.66%
Ordinary 2,356,357 $0.52 $0.52 1x $0.52 8.89%
To view CGeneTech’s complete cap table history, request access »

CGeneTech Patents

CGeneTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4530288-A1 Compound containing gem-difluoro group, preparation method therefor and use thereof Pending 05-Jul-2022
EP-4530288-A4 Compound containing gem-difluoro group, preparation method therefor and use thereof Pending 05-Jul-2022
WO-2024007976-A1 Compound containing gem-difluoro group, preparation method therefor and use thereof Inactive 05-Jul-2022
US-20250136608-A1 Compounds containing a gem-difluoride group and preparation method and use thereof Pending 05-Jul-2022
EP-4446322-A1 Cyclopropanamide-containing compound and use thereof Pending 18-Jan-2022 C07D471/04
To view CGeneTech’s complete patent history, request access »

CGeneTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CGeneTech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nanjing Herun Investment Growth/Expansion Minority
Bosera Capital Asset Manager Minority
Jiarui Capital Asset Manager Minority
Prosperity & Vision Asset Manager Minority
Suzhou Asset Management Asset Manager Minority
You’re viewing 5 of 18 investors. Get the full list »

CGeneTech FAQs

  • When was CGeneTech founded?

    CGeneTech was founded in 2010.

  • Where is CGeneTech headquartered?

    CGeneTech is headquartered in Suzhou, China.

  • What is the size of CGeneTech?

    CGeneTech has 83 total employees.

  • What industry is CGeneTech in?

    CGeneTech’s primary industry is Drug Discovery.

  • Is CGeneTech a private or public company?

    CGeneTech is a Private company.

  • What is CGeneTech’s current revenue?

    The current revenue for CGeneTech is .

  • How much funding has CGeneTech raised over time?

    CGeneTech has raised $94M.

  • Who are CGeneTech’s investors?

    Nanjing Herun Investment, Bosera Capital, Jiarui Capital, Prosperity & Vision, and Suzhou Asset Management are 5 of 18 investors who have invested in CGeneTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process